Pneumonia, Shingles, and Covid Immunization Rates and Associated Factors in Senior Housing Residents
Barbara Resnick1, Nicole Brandt2, Sarah Holmes1
1University of Maryland School of Nursing, Baltimore, MD, USA.
Vaccine rates for shingles, pneumonia, and COVID-19 were examined in older adults living in senior housing. Education was linked to shingles vaccination, while diabetes was linked to COVID-19 vaccination, but other demographic factors showed no association.
Area of Science:
- Gerontology
- Public Health
- Vaccinology
Background:
- Older adults, particularly those in low-income senior housing, may have varying immunization rates.
- Understanding factors influencing vaccine uptake is crucial for targeted public health interventions.
Purpose of the Study:
- To assess immunization rates for shingles, pneumonia, and COVID-19 among residents of low-income senior housing.
- To identify demographic and health-related factors associated with vaccine uptake in this population.
Main Methods:
- A cross-sectional study was conducted with 498 residents from 8 senior housing communities.
- Health intake assessments collected data on demographics, comorbidities, health status, lifestyle, and vaccination history.
Main Results:
- Pneumonia vaccine uptake was 59%, shingles vaccine at 43%, and COVID-19 vaccine at 79%.
- Higher education was associated with shingles vaccination.
- Diabetes was the only factor associated with COVID-19 vaccination.
Conclusions:
- Demographic factors, except education, did not significantly influence immunization rates in this senior housing population.
- Future research should explore health literacy's role in vaccine decision-making.
- Interventions should focus on educating individuals with lower education levels about immunization benefits and disease risks.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...